These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9421184)

  • 21. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
    Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA; Srivastava N; Averna M
    Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
    Kypreos KE
    Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesterol 7alpha-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells.
    Dueland S; France D; Wang SL; Trawick JD; Davis RA
    J Lipid Res; 1997 Jul; 38(7):1445-53. PubMed ID: 9254069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow.
    Van Eck M; Herijgers N; Vidgeon-Hart M; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
    Atherosclerosis; 2000 May; 150(1):71-80. PubMed ID: 10781637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL.
    Marchesi M; Parolini C; Caligari S; Gilio D; Manzini S; Busnelli M; Cinquanta P; Camera M; Brambilla M; Sirtori CR; Chiesa G
    Br J Pharmacol; 2011 Nov; 164(5):1460-8. PubMed ID: 21486287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Apolipoprotein E gene expression in peripheral blood monocyte in children with obesity].
    Xiang W; Ma YL; Chen C; Fu SM; Yang JF; Zhao SP; Guo DX; Zhao DC; Nie S; Wang FL
    Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):755-60. PubMed ID: 14731357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.
    Tsukamoto K; Hiester KG; Smith P; Usher DC; Glick JM; Rader DJ
    J Lipid Res; 1997 Sep; 38(9):1869-76. PubMed ID: 9323596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
    Li H; Reddick RL; Maeda N
    Arterioscler Thromb; 1993 Dec; 13(12):1814-21. PubMed ID: 8241102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells.
    Bielicki JK; McCall MR; Forte TM
    J Lipid Res; 1999 Jan; 40(1):85-92. PubMed ID: 9869653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.
    Sorci-Thomas MG; Zabalawi M; Bharadwaj MS; Wilhelm AJ; Owen JS; Asztalos BF; Bhat S; Thomas MJ
    Biochim Biophys Acta; 2012 Mar; 1821(3):502-12. PubMed ID: 21944998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High dietary n-6/n-3 PUFA ratio promotes HDL cholesterol level, but does not suppress atherogenesis in apolipoprotein E-null mice 1.
    Zhang L; Geng Y; Xiao N; Yin M; Mao L; Ren G; Zhang C; Liu P; Lu N; An L; Pan J
    J Atheroscler Thromb; 2009 Aug; 16(4):463-71. PubMed ID: 19729862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
    Hedrick CC; Hassan K; Hough GP; Yoo JH; Simzar S; Quinto CR; Kim SM; Dooley A; Langi S; Hama SY; Navab M; Witztum JL; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization.
    Shah PK; Yano J; Reyes O; Chyu KY; Kaul S; Bisgaier CL; Drake S; Cercek B
    Circulation; 2001 Jun; 103(25):3047-50. PubMed ID: 11425766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
    Tietge UJ; Maugeais C; Lund-Katz S; Grass D; deBeer FC; Rader DJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1213-8. PubMed ID: 12117740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice.
    Pedersen TX; Bro S; Andersen MH; Etzerodt M; Jauhiainen M; Moestrup S; Nielsen LB
    Atherosclerosis; 2009 Feb; 202(2):372-81. PubMed ID: 18489910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein association of human apolipoprotein E/A-I chimeras. Expression in transfected hepatoma cells.
    Thurberg BL; Reardon CA; Getz GS
    J Biol Chem; 1996 Mar; 271(11):6062-70. PubMed ID: 8626391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1.
    Su YR; Dove DE; Major AS; Hasty AH; Boone B; Linton MF; Fazio S
    Circulation; 2005 May; 111(18):2373-81. PubMed ID: 15851589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.